The APULEIO study showed that apixaban per se or as a component of an optimized medical therapy is useful to reach a positive impact on depressive symptoms in frail and disabled patients, and on HRQL in disabled subjects.

Apixaban and the improved psychologic profile in frailty and disability. Myth or reality? / Fumagalli, Stefano; Di Pasquale, Giuseppe; Molon, Giulio; Agnelli, Giancarlo; Marchionni, Niccolò. - In: EUROPEAN JOURNAL OF INTERNAL MEDICINE. - ISSN 0953-6205. - ELETTRONICO. - (2025), pp. 1-2. [10.1016/j.ejim.2025.03.012]

Apixaban and the improved psychologic profile in frailty and disability. Myth or reality?

Fumagalli, Stefano
;
Marchionni, Niccolò
2025

Abstract

The APULEIO study showed that apixaban per se or as a component of an optimized medical therapy is useful to reach a positive impact on depressive symptoms in frail and disabled patients, and on HRQL in disabled subjects.
2025
1
2
Goal 3: Good health and well-being
Fumagalli, Stefano; Di Pasquale, Giuseppe; Molon, Giulio; Agnelli, Giancarlo; Marchionni, Niccolò
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0953620525000986-main.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 304.77 kB
Formato Adobe PDF
304.77 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1416558
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact